Every encounter between a T cell and a potential target—especially when that target is a developing tumor—begins with a rapid ...

Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies the ...

In many animal tissues, stem cells continually divide to create new cells that replace old or damaged ones. However, this ...

Signalling between neurons and tumour cells in the lung and brain promotes the growth of small-cell lung cancer. These interactions might be a therapeutic target. Read the paper: Neuronal ...

Malignant melanoma is one of the most dangerous forms of cancer. Around half of melanomas and about 7% of all other cancers ...

A new research perspective was published in Volume 13 of Oncoscience on June 3, 2026, titled "The dual axis of tumorigenesis: ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...

The blood–brain barrier (BBB) is a specialized vascular interface that strictly regulates the exchange of cells and molecules between the bloodstream and ...

Newly discovered protein conformation offers a potential target for cancer drugs. Villigen, 21.07.2026 — Several types of ...

Researchers at KAIST and Yonsei University have mapped the structural mechanism by which cells translate nutrient cues into ...

The naked mole-rat, a nearly hairless, wrinkled rodent native to East Africa, can live more than 37 years and shows almost no signs of cancer across its lifespan. A 15-year pathology survey of 138 ...